Jasper Kurth has assumed the position as CEO

01 Aug 2024 07:30 CEST

1.8.2024 07:30:00 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state

Oslo, Norway, 1 August 2024: Mr. Jasper Kurth has assumed the position as CEO of
Thor Medical with effect from 1 August, replacing Alf Bjørseth who will remain
with the company as Senior Vice President & Strategic Advisor. Reference is made
to the stock exchange announcement issued on 14 February regarding the Board's
engagement of Jasper Kurth as new CEO.

Mr. Kurth joins Thor Medical from Bayer Pharmaceuticals where he has held
several positions, most recently as General Manager Radiology Nordics in
Stockholm, and prior to that as Head of Business Operations & Strategy EMEA,
Head of Sub-Region Western Europe Radiology (acting), and Chief of Staff and
Head of Training Radiology Europe.

«I am very much looking forward to starting with Thor Medical and joining a team
dedicated to revolutionizing healthcare and improving the lives of patients
battling cancer. There is a strong and rapidly growing demand for thorium in
radiotherapeutic applications, and we have many important milestones ahead in
the coming months, quarters, and years," says Jasper Kurth.

As previously announced, Dr. Alf Bjørseth will continue to support the company's
client acquisition activities and technical development of a production facility
for thorium-based alpha emitters at Herøya, Norway as Senior Vice President &
Strategic Advisor.

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.

CONTACTS

* Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.no

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - https://www.thormedical.no.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18188812/4802/Download%20announce
ment%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

624303_Download announcement as PDF.pdf